HEALTH.2010.2.4.1-8
HEALTH.2010.2.4.1-8
5 projects · €29,835,645 total EU contribution (project-level) · 44 participating organizations · 15 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€29,835,645
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (10)
- Germany (6)
- Netherlands (6)
- France (5)
- Spain (3)
- BE (2)
- DK (2)
- IE (2)
- Italy (2)
- AT (1)
- CH (1)
- HU (1)
- IS (1)
- RO (1)
- SE (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- NKI AVL4 projects · NL
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3 projects · UK
- Leiden University Medical Center2 projects · NL
- AG2 projects · NL
- IDIBELL-CERCA2 projects · ES
- FUNDACION PRIVADA INSTITUTO DEINVESTIGACION ONCOLOGICA DE VALL-HE2 projects · ES
- Horizon Discovery Limited2 projects · UK
- ARTTIC1 projects · BE
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1 projects · FR
- ARTIC1 projects · FR
- ASTRAZENECA UK LIMITED1 projects · UK
- GOMN1 projects · IT
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
European collaborative project on Targeted therapy in renal cell cancer: genetic and tumor-related biomarkers for response and toxicity EUROTARGET · 259939 | FP7 | €5,999,550 | €7,818,367 | Details |
Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics PREDICT · 259303 | FP7 | €5,841,009 | €7,964,979 | Details |
Modelling and predicting sensitivity to targeted therapies in colorectal cancers COLTHERES · 259015 | FP7 | €5,999,300 | €8,200,254 | Details |
Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes RATHER · 258967 | FP7 | €5,995,786 | €7,812,555 | Details |
The DNA damage response and breast cancer DDRESPONSE · 259893 | FP7 | €6,000,000 | €8,165,981 | Details |